Yoko Hibi-Furukawa
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Time-saving impact of two generation model chemotherapy compounding robots on pharmacists' daily workflow: A long-term evaluation.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: April 02, 2026
Prognostic Impact of Early GNRI Sustainability in Metastatic Urothelial Carcinoma Receiving Pembrolizumab.
Journal: Anticancer research
Published: January 23, 2026
Eosinophil Proportion May Serve as a Candidate Biomarker for Adverse Events in Patients With Urothelial Carcinoma Treated With Enfortumab Vedotin.
Journal: Cancer medicine
Published: January 14, 2026
Integrating pharmacokinetic modeling and wearable-derived physiological data to assess pain intensity in patients with advanced urologic cancer.
Journal: Japanese journal of clinical oncology
Published: October 28, 2025
Sustained Drug-Drug Interaction Between Cyclosporine and Apalutamide in a Patient With Metastatic Hormone-Sensitive Prostate Cancer: A Case Report and Evaluation of CYP3A4 Induction via Pregnane X Receptor Activation by Apalutamide.
Journal: Case reports in oncological medicine
Published: October 21, 2025
Successful multimodal treatment of venlafaxine overdose-induced catecholamine-refractory shock: a case report.
Journal: The Journal of toxicological sciences
Published: October 01, 2025
A high eosinophil proportion increases the risk of skin-related adverse events induced by apalutamide in patients with prostate cancer.
Journal: Frontiers in immunology
Published: August 07, 2025
Impact of high relative dose intensity on effectiveness and treatment continuity of IO-TKI therapy in Japanese advanced renal cell carcinoma.
Journal: Scientific reports
Published: July 10, 2025
Elevation of Eosinophil Proportion After Pembrolizumab Increases the Risk of Immune-Related Adverse Events in Patients With Bladder Cancer.
Journal: Cancer medicine
Published: June 26, 2025
Amrubicin monotherapy for refractory, relapsed, small cell lung cancer in elderly patients.
Journal: Japanese journal of clinical oncology
Published: June 01, 2025
Severe symptomatic cardiac dysfunction in a patient with BRAF V600E-mutated metastatic colorectal cancer treated with encorafenib, binimetinib, and cetuximab: a case report.
Journal: Journal of pharmaceutical health care and sciences
Published: May 08, 2025
Efficacy and safety of anamorelin in patients with metastatic urothelial carcinoma receiving systemic chemotherapy: a randomized controlled study.
Journal: The oncologist
Published: April 04, 2025
Last Updated: 09/26/2026